top of page

Latest News

Mar 17, 2023

5 most promising Fintech startups

This is placeholder text. To change this content, double-click on the element and click Change Content.

Read More
5 most promising Fintech startups
texture_bg.jpg

SpyGlass Pharma™  Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer

ALISO VIEJO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, today announced the appointment of Chetan Pujara, Ph.D., as Chief Research & Development Officer. Dr. Pujara brings over 20 years of leadership experience in pharmaceutical and drug-device combination product development across ophthalmic, neurological, dermatological and infectious disease areas. (View full press release)

Spyglass Pharma Logo - Long - Black_edited.png

Technology

Tel: 949-284-6904

About

27061 Aliso Creek Rd, Suite 100
Aliso Viejo, CA 92656

Investors

CONTACT US

SUBSCRIBE

Sign up to receive SpyGlass Pharma™ news and updates.

Thanks for submitting!

SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer

© 2025 SpyGlass Pharma™. All Rights Reserved.

Follow us on LinkedIn

  • LinkedIn
bottom of page